Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond
Alpo Vuorio, Petri T. Kovanen
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 23

Showing 23 citing articles:

Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study
Hamideh Kouhpeikar, Hamidreza Khosaravizade Tabasi, Zahra Khazir, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 45
The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study
Srikanth Umakanthan, Sanjum Senthil, Stanley John, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment
Alpo Vuorio, Frederick J. Raal, Markku Kaste, et al.
Atherosclerosis (2021) Vol. 320, pp. 53-60
Open Access | Times Cited: 31
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets
Maria Proto, Donatella Fiore, Chiara Piscopo, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101099-101099
Open Access | Times Cited: 29
Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review
Bharti Sharma, Skarma Nonzom
Current Microbiology (2023) Vol. 80, Iss. 10
Closed Access | Times Cited: 6
SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease
Petri T. Kovanen, Alpo Vuorio
Atherosclerosis Plus (2023) Vol. 53, pp. 1-5
Open Access | Times Cited: 5
The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity
Yousef Rasmi, Nadia Heidari, Kevser Kübra Kırboğa, et al.
Clinical Biochemistry (2022) Vol. 104, pp. 1-12
Open Access | Times Cited: 9
Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
Alpo Vuorio, Timo Strandberg, Frederick J. Raal, et al.
Atherosclerosis Plus (2021) Vol. 43, pp. 3-6
Open Access | Times Cited: 11
Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
Alpo Vuorio, Markku Kaste, Petri T. Kovanen
eNeurologicalSci (2021) Vol. 23, pp. 100344-100344
Open Access | Times Cited: 9
Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic
Helen Huang, Keith Sai Kit Leung, Tulika Garg, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 8, pp. 831-844
Open Access | Times Cited: 3
Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
Petri T. Kovanen, Frederick J. Raal, Alpo Vuorio
American Journal of Preventive Cardiology (2021) Vol. 7, pp. 100224-100224
Open Access | Times Cited: 7
Polyketides from Fungi
Christiane Contigli, Marcelo Siqueira Valle, Sı́lvia Catarina Salgado Oloris, et al.
Springer eBooks (2023), pp. 555-605
Closed Access | Times Cited: 2
Should statins be considered for the management of mucormycosis in COVID-19?
Subhankar Chatterjee, Bhagya Vardhan, Deepa Kumari Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 4, pp. 102162-102162
Open Access | Times Cited: 6
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a reference
Alpo Vuorio, Bruce Budowle, Frederick J. Raal, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
Klotho Deficiency in Severe COVID-19: A Unifying Hypothesis
Natalia Campos‐Obando, M. Carola Zillikens, Román F. Macaya
COVID (2024) Vol. 4, Iss. 12, pp. 1833-1850
Open Access
Statin-Induced Mitochondrial Damage
Jarmila Kucharská, Alena M. Langsjoen, Peter H. Langsjoen
Advances in biochemistry in health and disease (2024), pp. 263-283
Closed Access
Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten
Alpo Vuorio, Frederick J. Raal, Petri T. Kovanen
Journal of clinical lipidology (2022) Vol. 16, Iss. 5, pp. 757-758
Open Access | Times Cited: 3
Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
Alpo Vuorio, Riitta Lassila, Petri T. Kovanen
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 4
Venous Thromboembolism and COVID-19—an Epidemiological Perspective
Ajay Khanna, Divya Khanna
Indian Journal of Surgery (2022) Vol. 85, Iss. S1, pp. 133-140
Open Access | Times Cited: 2
Familial Hypercholesterolemia Patients with COVID-19—Effective Cholesterol-Lowering Therapy is Urgent both during and after Infection
Alpo Vuorio, Frederick J. Raal, Petri T. Kovanen
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 12, pp. 410-410
Open Access | Times Cited: 1
Adjunctive Use of Statins for COVID-19
Mike Sathekge, Geert Byttebier, Bart De Spiegeleer, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1407-1407
Open Access | Times Cited: 1
Covid-19 in a Patient with Congenital Analbuminemia and Coronary Artery Disease: A Case Report
Sana Aboulkacem, Yessine Amri, A. Tezeghdenti, et al.
Mathews Journal of Case Reports (2023) Vol. 8, Iss. 2
Open Access
Estatinas y efectos pleiotrópicos en COVID-19: una revisión exploratoria
Juan Felipe Coronado-Sarmiento, Eduardo Tuta-Quintero, Alejandra Lozano, et al.
Boletín de Malariología y Salud Ambiental (2021) Vol. 61, Iss. ee2, pp. 16-25
Open Access
Page 1

Scroll to top